Tim Smit
Press officer
- European Investment Bank
- Communication Department
- 98-100, boulevard Konrad Adenauer
- L-2950 Luxembourg
- Luxembourg
+352 4379 - 89076
+352 691286423
+352 4379 - 61000
More press releases
18 July 2025
Netherlands: European boost for global food security: Dutch biotech Solynta gets €20 million EIB backing for highly disease resistant potato varieties
The European Investment Bank (EIB) has signed a €20 million venture debt financing agreement with Dutch biotechnology company Solynta, to accelerate the development of potato varieties with enhanced resistance to disease and resilience to climate change. Solynta will use the EIB support for its research into the use of true potato seeds instead of traditional tubers for cultivation.
16 July 2025
Netherlands: EIB, Rabobank, and DLL partner to provide €1 billion for European SMEs with a focus on sustainability and agriculture
Rabobank, DLL, and the European Investment Bank are partnering to increase access to finance for SMEs and mid-caps with a particular emphasis on sustainability and bioeconomy sectors, including agriculture.
3 June 2025
The Netherlands: Leyden Labs lands €20 million EIB investment facilitated by HERA to advance pandemic preparedness activities
The European Investment Bank (EIB) and Dutch clinical-stage biotechnology company Leyden Laboratories B.V. have signed a €20 million financing deal to advance development of the Company’s broadly-protective antibodies to defend against seasonal and pandemic viral infections. Leyden Labs’ lead program is a pan-influenza nasal spray currently in clinical development (PanFlu), which has the potential to provide first-in-class influenza protection and meaningfully reduce the burden of influenza infection, including in infection from Avian Flu (H5).